Published in Ann Surg on September 01, 1983
Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91
Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med (1984) 2.44
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Treatment of homozygous familial hypercholesterolaemia: an informative sibship. Br Med J (Clin Res Ed) (1985) 1.04
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
Surgical portosystemic shunts and the Rex bypass in children: a single-centre experience. HPB (Oxford) (2009) 0.84
Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy. Hepatology (1983) 0.80
Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia. Hum Gene Ther Clin Dev (2017) 0.79
Ultrastructural characteristics of hyperplastic alterations in the liver of congenital portacaval-shunt rats. Br J Exp Pathol (1984) 0.79
Plasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresis. Proc Natl Acad Sci U S A (1986) 0.77
Familial hypercholesterolaemia. J R Soc Med (1987) 0.75
The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75
Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65
Evolution of liver transplantation. Hepatology (1982) 19.54
A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27
Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem (1974) 9.02
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A (1975) 3.16
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci U S A (1981) 2.82
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest (1975) 2.65
Management of extrahepatic portal hypertension in children. Ann Surg (1974) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg (1973) 1.91
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
Physical-chemical basis of lipid deposition in atherosclerosis. Science (1974) 1.63
Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis (1977) 1.52
Hepatotrophic substances. Prog Liver Dis (1979) 1.39
Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A (1982) 1.35
Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg (1976) 1.11
Rate constants for the uptake of cholesterol from various intestinal and serum lipoprotein fractions by the liver of the rat in vivo. Biochim Biophys Acta (1977) 1.10
Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia. Lancet (1974) 1.00
Treatment of homozygous familial hypercholesterolaemia with probucol. S Afr Med J (1982) 0.99
Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias. Ann Surg (1974) 0.98
Low density and high density lipoprotein turnover following portacaval shunt in swine. J Lipid Res (1976) 0.91
Portacaval shunt in four patients with homozygous hypercholesterolaemia. Lancet (1975) 0.90
Effect of portacaval shunt and arterialization of the liver on bile acid metabolism. Gastroenterology (1975) 0.89
Cholesterol metabolism following portacaval shunt in the pig. Atherosclerosis (1976) 0.89
Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels. Arch Surg (1977) 0.88
Letter: Portacaval shunt in hyperlipidaemia. Lancet (1974) 0.88
The effect of portacaval shunt on plasma lipids and tissue cholesterol synthesis in the dog. Surgery (1976) 0.86
Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. Gastroenterology (1977) 0.86
Decreased cholesterol and fatty acid synthesis following portacaval shunt. Surg Forum (1977) 0.85
The effect of selective visceral caval shunt on plasma lipids and cholesterol dynamics. Surgery (1977) 0.84
Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia. S Afr Med J (1976) 0.84
Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting. Biochim Biophys Acta (1982) 0.84
Cholesterol homeostasis in the rat with a portacaval anastomosis. Proc Natl Acad Sci U S A (1979) 0.83
Letter: Portocaval shunt for hypercholesterolaemia. S Afr Med J (1974) 0.83
Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. Atherosclerosis (1982) 0.83
Lipid and lipoprotein secretion following portacaval shunt in swine. Atherosclerosis (1978) 0.82
Combined hypolipidemia of portacaval transposition and ileal resection in the dog. Surg Gynecol Obstet (1980) 0.82
Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia. Lancet (1976) 0.81
The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons. J Surg Res (1980) 0.81
Plasma lipids and hepatic lipid synthesis following portacaval shunt in the rat. S Afr Med J (1978) 0.81
Effect of portacaval anastomosis on the activities of hepatic enzymes related to cholesterol and bile acid metabolism in rats. Biochim Biophys Acta (1976) 0.81
[Treatment of type II familial hypercholesteremia through portacaval anastomosis]. Arch Fr Pediatr (1976) 0.80
Hypercholesterolemia, portacaval shunt and coronary disease. N Engl J Med (1979) 0.80
[End to side porto-caval shunt in familial type II homozygote hypercholesterolemia (author's transl)]. Chir Pediatr (1979) 0.80
Portacaval shunt for familial heterozygous hypercholesterolemia. Surg Gynecol Obstet (1981) 0.80
The defect of uric acid metabolism in Eck-fistula rats. J Lab Clin Med (1977) 0.79
Portacaval shunt and whole-body cholesterol metabolism in the cholesterol-fed African green monkey. Proc Soc Exp Biol Med (1979) 0.78
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Catheter technique for recording His bundle activity in man. Circulation (1969) 6.01
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol (1989) 4.69
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell (1999) 4.25
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting. Circulation (1991) 3.90
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) JAMA (1996) 3.52
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc Natl Acad Sci U S A (1998) 3.18
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child (1979) 3.16
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14